Janux Therapeutics
JANX
JANX
64 hedge funds and large institutions have $360M invested in Janux Therapeutics in 2023 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 27 increasing their positions, 11 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2% more capital invested
Capital invested by funds: $354M → $360M (+$6.28M)
3.39% less ownership
Funds ownership: 76.1% → 72.71% (-3.4%)
Holders
64
Holding in Top 10
–
Calls
$60K
Puts
$10K
Top Buyers
| 1 | +$1.78M | |
| 2 | +$1.06M | |
| 3 | +$990K | |
| 4 |
Cerity Partners
New York
|
+$527K |
| 5 |
ZIM
Zacks Investment Management
Chicago,
Illinois
|
+$509K |
Top Sellers
| 1 | -$14.5M | |
| 2 | -$2.69M | |
| 3 | -$1.18M | |
| 4 |
JP Morgan Chase
New York
|
-$1.13M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$1.08M |